chr1:199996742:> Detail (hg19)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr1:199,996,742-200,146,548 |
hg38 | chr1:200,027,614-200,177,420 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.120 | ulcerative colitis | NA | BeFree,GWASCAT | Detail | |
<0.001 | colorectal carcinoma | In this work, we address this question through shRNA-mediated silencing of LRH-1... | BeFree | 25675535 | Detail |
<0.001 | Colorectal Neoplasms | NA | BeFree | Detail | |
<0.001 | Crohn Disease | NA | BeFree | Detail | |
0.003 | Endometrial Neoplasms | NA | LHGDN | Detail | |
<0.001 | Graft-vs-Host Disease | NA | BeFree | Detail | |
0.003 | hepatitis B | NA | BeFree,LHGDN | Detail | |
0.120 | Female infertility | NA | CTD_human | Detail | |
<0.001 | Mammary Ductal Carcinoma | NA | BeFree | Detail | |
<0.001 | Inflammatory Bowel Diseases | NA | BeFree | Detail | |
<0.001 | Intestinal Neoplasms | NA | BeFree | Detail | |
0.003 | leukemia | NA | LHGDN | Detail | |
<0.001 | myeloid leukemia | NA | BeFree | Detail | |
<0.001 | Myeloid Leukemia, Chronic | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of stomach | Associations of NR5A2 gene polymorphisms with the clinicopathological characteri... | BeFree | 25514243 | Detail |
0.002 | osteoporosis | NA | GAD | Detail | |
<0.001 | osteosarcoma | Therefore, miR-451-induced suppression of LRH-1 can be a novel therapy to treat ... | BeFree | 25869073 | Detail |
0.003 | Stomach Neoplasms | NA | LHGDN | Detail | |
0.002 | Tobacco use disorder | NA | GAD | Detail | |
<0.001 | Tumor Progression | Liver receptor homolog-1 (LRH-1, NR5A2) is an orphan nuclear receptor that has a... | BeFree | 25435372 | Detail |
<0.001 | embryonal carcinoma | NA | BeFree | Detail | |
<0.001 | Cystadenocarcinoma, Serous | NA | BeFree | Detail | |
0.002 | pancreatic carcinoma | NA | BeFree | Detail | |
0.125 | Pancreatic Neoplasm | NA | GAD | Detail | |
<0.001 | intestinal cancer | NA | BeFree | Detail | |
0.124 | Malignant neoplasm of pancreas | NA | BeFree,GAD,GWASCAT | Detail | |
<0.001 | Osteosarcoma of bone | Therefore, miR-451-induced suppression of LRH-1 can be a novel therapy to treat ... | BeFree | 25869073 | Detail |
0.001 | Carcinogenesis | Reduction of LRH-1 diminishes tumor burden in murine models of CRC; however, it ... | BeFree | 25675535 | Detail |
0.003 | breast carcinoma | Analysis of breast cancer samples reveals that a high LRH-1 level is inversely c... | BeFree | 25435372 | Detail |
<0.001 | colon carcinoma | Silencing LRH-1 in colon cancer cell lines impairs proliferation and alters gene... | BeFree | 25675535 | Detail |
<0.001 | stomach carcinoma | Associations of NR5A2 gene polymorphisms with the clinicopathological characteri... | BeFree | 25514243 | Detail |
<0.001 | Invasive breast carcinoma | NA | BeFree | Detail | |
<0.001 | breast adenocarcinoma | NA | BeFree | Detail | |
<0.001 | Invasive Ductal Breast Carcinoma | NA | BeFree | Detail | |
<0.001 | Morphologically altered structure | Scanning electron microscopy and transmission electron microscopy verified the m... | BeFree | 25098547 | Detail |
0.003 | Mammary Neoplasms | NA | BeFree,LHGDN | Detail | |
<0.001 | colorectal cancer | In this work, we address this question through shRNA-mediated silencing of LRH-1... | BeFree | 25675535 | Detail |
0.120 | anovulation | NA | CTD_human | Detail | |
0.003 | Malignant neoplasm of breast | Analysis of breast cancer samples reveals that a high LRH-1 level is inversely c... | BeFree | 25435372 | Detail |
<0.001 | Malignant tumor of colon | Silencing LRH-1 in colon cancer cell lines impairs proliferation and alters gene... | BeFree | 25675535 | Detail |
<0.001 | Noninfiltrating Intraductal Carcinoma | NA | BeFree | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NA | DisGeNET | Detail |
In this work, we address this question through shRNA-mediated silencing of LRH-1 in established CRC ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Associations of NR5A2 gene polymorphisms with the clinicopathological characteristics and survival o... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Therefore, miR-451-induced suppression of LRH-1 can be a novel therapy to treat osteosarcoma. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Liver receptor homolog-1 (LRH-1, NR5A2) is an orphan nuclear receptor that has an essential role in ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Therefore, miR-451-induced suppression of LRH-1 can be a novel therapy to treat osteosarcoma. | DisGeNET | Detail |
Reduction of LRH-1 diminishes tumor burden in murine models of CRC; however, it is not known whether... | DisGeNET | Detail |
Analysis of breast cancer samples reveals that a high LRH-1 level is inversely correlated with CDKN1... | DisGeNET | Detail |
Silencing LRH-1 in colon cancer cell lines impairs proliferation and alters gene expression programs... | DisGeNET | Detail |
Associations of NR5A2 gene polymorphisms with the clinicopathological characteristics and survival o... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Scanning electron microscopy and transmission electron microscopy verified the morphologic changes o... | DisGeNET | Detail |
NA | DisGeNET | Detail |
In this work, we address this question through shRNA-mediated silencing of LRH-1 in established CRC ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Analysis of breast cancer samples reveals that a high LRH-1 level is inversely correlated with CDKN1... | DisGeNET | Detail |
Silencing LRH-1 in colon cancer cell lines impairs proliferation and alters gene expression programs... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs60636333 dbSNP
- Genome
- hg19
- Position
- chr1:199,996,742-200,146,548
- Variant Type
- snv
Genome browser